PTC Therapeutics director Michael Schmertzler disposes of USD 1.35 million in common shares - PTCT News | RalliesPTC Therapeutics director Michael Schmertzler disposes of USD 1.35 million in common shares
P
PTCT• Director sales disclosed in filing
- PTC Therapeutics director Michael Schmertzler reported sales of 20,000 common shares on Sept. 9-10, 2026.
- Shares sold at weighted average prices of USD 67.79, USD 68.67, USD 67.34.
- Indirect stake fell to 1,316,594 shares following the transactions.
HE
•
